healthcare industry Archives - Business Intelligence

Tag: healthcare industry

Healthcare M&A + M&A Support

Overcoming the Impact of COVID-19 and Preparing for a New Future in Healthcare M&A

The healthcare sector is facing tumultuous times in 2020. With the widespread COVID-19 pandemic, major business operations are disrupted, hospitals are overloaded, medical professionals are overworked, and healthcare institutions’ boards attempt to maintain normalcy. Healthcare M&A is one such crucial segment of the healthcare sector that was nearly brought to a screeching halt in the second quarter of 2020.

An increasing number of cases in North American countries and some parts of Europe and APAC have worsened the state of economies and industries. Although the healthcare and pharmaceutical industries have devoted their time and effort to the COVID-19 pandemic, the world is still a long way from a vaccine or normalcy of any kind. Consequently, this poses a challenge for the aforementioned hospitals, medical professionals, and healthcare institutions’ boards.

Currently, healthcare institutions are in the midst of a crisis with no clear ending. While investor support has increased due to the increasing need for healthcare globally, social and political unrest, struggling economies, and volatility in financial markets are testing the healthcare industry. Healthcare M&A may be one of the most effective solutions to this crisis.

In this article, Infiniti’s M&A support team has detailed the impact of the COVID-19 crisis on healthcare M&A, positive factors influencing the recovery of healthcare M&A, and the importance of M&A support.

The COVID-19 crisis has severely impacted healthcare M&A. To learn the business implications of COVID-19 on healthcare M&A, speak to our industry experts.

The Impact of COVID-19 on Healthcare M&A

The COVID-19 pandemic has taken a substantial toll on developing healthcare mergers and ongoing healthcare M&A deals. Infiniti’s experts identified the following three major challenges that healthcare institutions can expect to impact the healthcare M&A process:

Healthcare M&A + M&A Support

Regulatory Delays

Nationwide lockdowns in countries, including the United States, New Zealand, and the United Kingdom, has caused a severe delay in acquiring regulatory clearance. With all operations on hold, government bodies focusing on COVID-19 related issues, and professionals being forced to work from home, all-important regulatory approval processes have been on hold. However, companies can fast track their M&A processes by ensuring other parts of the process have been completed before the situation normalizes.

Changing Valuations

The impact of COVID-19 on healthcare M&A participants in ongoing deals will potentially change both the buyer and the seller’s valuation. This may lead to the collapse of previous deals or the need for re-valuation of both parties. Revision of the purchase price and financial statements accounting for the COVID-19 impact may help fast-track this process. However, this may still impact potential or ongoing healthcare mergers due to the continuing effects of COVID-19 and an unclear deadline on the crisis.

Due Diligence and Third-Party Approval

Healthcare M&A requires rigorous due diligence from both parties involved. Due to the lockdowns, new safety and hygiene protocols, and the need for social distancing, this process has been delayed, if not stopped. Additionally, both parties may request another round of thorough due diligence in the case of ongoing mergers. Further, third party activities such as audits, on-site visits, and inspections will be delayed, slowing down the M&A process for healthcare institutions.

Understanding the challenges of healthcare M&A is the first step towards successful mergers for healthcare companies. To gain a more comprehensive understanding of the challenges and how your organization can tackle them, request more information.

The Path to Recovery

The world is working towards recovery, pharmaceutical, and healthcare sectors worldwide are attempting to develop a vaccine. Simultaneously, governments are taking initiatives and providing support to industries to reduce the COVID-19 crisis’s impact. However, this process is expected to be slow and long-drawn. Therefore, Infiniti’s experts have highlighted the following two minor factors positively impacting healthcare M&A:

  • The hospital segment, innovation-focused biotech stocks, and large pharma companies may see a surge in valuation due to the high dependence on hospitals and the ongoing work to find a vaccine. This may encourage multiple buy-outs and influence extremely attractive valuations.
  • The capital position of private equity firms is expected to provide them with the opportunity to assess and capture resilient assets shortly.

Although there are limited positive factors influencing healthcare M&A currently, increasing demand for healthcare services and relatively minimal disruptions may fuel growth in this space. However, companies must evaluate their M&A partners and enter into healthcare mergers cautiously in these challenging times.

Importance of M&A Support during the Healthcare M&A Process

The recovering healthcare M&A sector has yet to face various challenges posed by the jarring COVID-19 crisis. As companies continue, plan, or complete deals, they must evaluate all potential risks and gain a comprehensive understanding of their partners. Infiniti’s M&A support solutions enable companies to identify, assess, and prepare for all the factors that influence any healthcare M&A.

Infiniti’s M&A support also provides healthcare companies with the following:

  • Assistance with identifying ideal partnerships and potentially beneficial mergers
  • Expert insights into appropriate valuation and important decisions regarding transactions and investments
  • A comprehensive understanding of every stage and process in the healthcare M&A process
  • Data-drive insights that also account for the changing landscape and current competitive scenario of the healthcare industry

Infiniti’s M & A support experts can help companies tackle the challenges caused by the COVID-19 pandemic and identify and evaluate the risks involved in potential deals. This will enable companies to stay a step ahead of competitors, identify and assess ideal opportunities, and keep abreast of all factors influencing the healthcare M&A process.

Leveraging Infiniti’s M&A support solutions can help identify the ideal partnership, maintain business continuity through the COVID-19, and overcome the business implications of this crisis. Request a FREE proposal to learn more about the value of M&A support solutions in the recovering healthcare M&A space.

Patient journey mapping

Patient Journey Mapping Helped a Healthcare Company to Understand Patient Behavior and Increase Business Outcome

Changing economic and demographic characteristics are affecting the healthcare needs of patients worldwide. For healthcare companies, patient satisfaction is likely to become an increasingly important source of competitive advantage. The key to patient engagement and satisfaction is identifying gaps in offerings and delivering exceptional customer service. As such, healthcare companies worldwide are focusing on understanding how patients interact with a hospital or health system throughout their care journey. This is where patient journey mapping comes into play. By leveraging patient journey mapping solution, healthcare companies can identify gaps that may hinder their relationship-building during preclinical phases, create personalized experiences for each patient, and unlock opportunities to improve pre and post-clinical patient engagement.

Recent statistics show that healthcare providers that emphasize the customer experience achieve greater revenue than providers that do not prioritize the customer experience. Our patient journey mapping engagement can help you to enhance the customer experience. Request a FREE proposal here.

Business Challenge

The client is a healthcare company based out of the United Arab Emirates.

A healthcare company encountered a stagnant growth for two consecutive years. Also, they were losing ground to competitors. To stay competitive and retain valuable patients, they wanted to better understand patient experiences during every stage of interaction with the health system, match their business objectives with ever-changing market forces, and build long-term patient relations. Besides, to efficiently engage today’s value-driven customers, the client wanted to identify areas for improvement by mapping the entire patient journey and focus on creating excellent experiences for their patients. To do so, they chose to collaborate with Infiniti Research to leverage their expertise in offering patient journey mapping.

Other key objectives of the client were:

  • Understanding patient behavior throughout every stage of their care journey
  • Understanding patients’ needs, demands, and preferences
  • Understanding the gaps and opportunities to improve patient communication
  • Improving patient engagement through timely and targeted outreach efforts
  • Keeping up with shifting market forces to ensure high rates of patient acquisition and retention
  • Creating personalized experiences for each patient by deeply understanding their needs and preferences
  • Improving pre-clinical customer engagement
  • Uncovering latent market opportunities
  • Examining how you stack up against competitors throughout the customer journey

By leveraging patient journey mapping, leading healthcare companies are crafting a strategic and personalized approach to keep their patients engaged during the whole journey. Don’t get left behind. Contact us to leverage patient journey mapping solution.

Our Integrated Approach

The experts at Infiniti Research followed a detailed approach to patient journey mapping.

We began with comprehensive patient journey mapping for different diagnostic services. We also had in-depth interviews with internal team members to identify bottlenecks. Besides, open-ended interviews with patients and their relatives were conducted to identify patients’ pain points.

The next phase of the patient journey mapping engagement involved following data collection methods such as one-on-one patient and one-on-one staff interviews to help the client understand their patients’ thoughts, feelings, and actions when they interact with the health system.

The next phase involved gathering internal patient satisfaction survey data to understand patient behavior throughout every stage of their care journey. This phase of the engagement also involved using the patient experience survey data to identify patients’ pain points.

The final phase of the engagement involved making a list of the high-volume services that have a significant impact on the client’s bottom line. Besides, deep-dive secondary research by seasoned analysts was conducted to gather available information and insights. Also, validation of market data and study results with market experts and independent consultants were conducted.

Business Outcome

With Infiniti’s patient journey mapping solution, the client was able to improve health outcomes, patient experience and engagement. Also, patient journey mapping helped the client to reduce the likeliness of missed appointments and readmissions.

With Infiniti’s patient journey mapping engagement, the client was able to create personalized experiences for each patient by deeply understanding their needs and keep up with shifting market forces to ensure high rates of patient acquisition and retention. Also, the client was able to better understand patient experiences throughout each stage of interaction with the health system and identify gaps and opportunities for improvement in patient communications. In addition to this, the client was also able to explore opportunities to improve pre- and post-clinical patient engagement through timely, targeted outreach efforts and boosts retention rates by reinforcing long-term patient relationships.

In a short period of 90 days, the results of patient journey mapping have been extremely encouraging for the client, both in terms of employee engagement and patient experience. Subsequently, the healthcare industry client was able to realize savings of over 1.8 million AED.

Want to know more about our patient journey mapping engagement? Request more info and our experts will get in touch with you with detailed insights.

US healthcare

Staying Prepared to Combat the Pandemic: Lessons for the US Healthcare Industry from Italy’s Response Flaws

The WHO (World Health Organization) ranks Italy among the top 10 countries with high quality of healthcare and related services in the world. Although the Italian healthcare system is far from perfect, this rating by the WHO is largely based on equality of healthcare access and other healthcare outcomes such as life expectancy and healthy life years of the population. Despite displaying qualities of a higher level of care and healthcare services, Italy is currently the new epicenter for COVID-19.  Despite now having some of the toughest measures in the world to contain the spread of the pandemic, Italian authorities were slow to react and fumbled many of those steps in the early stages of the contagion as they sought to preserve basic civil liberties as well as the economy, raising the fatality of the coronavirus outbreak in the country. The number of reported coronavirus positive cases in the US has skyrocketed over the past few weeks, and the death toll from COVID-19 in the US is not far behind from that of Italy. The rising number of cases has already overwhelmed the US healthcare industry. In this article, healthcare industry experts at Infiniti Research outline some key takeaways for the US healthcare industry from Italy’s flawed response to the outbreak and how healthcare companies in the US can prevent themselves from a similar fate.

US healthcare industry COVID-19

Ensuring protection of healthcare staff  

The US has surpassed the initial phase where the spread of the COVID-19 can be contained completely. As such, what companies in the US healthcare industry need now is to be equipped with the staff and resources to cater to the rising number of cases in the country. In Italy, over 2500 healthcare workers have become victims of the novel coronavirus outbreak. They account for approximately 20% of Italy’s healthcare staff who are out of action due to active infection and are subject to isolation or even death due to the virus.

The US healthcare industry cannot afford a similar situation at the current state, as such, they must ensure the safety of healthcare staff at all costs. Appropriate PPE should be provided to the staff based on the area in which they work Furthermore, supplies should be plentiful and necessary training must be imparted to the staff on guidelines to treat coronavirus patients. Apart from this, it is vital to offer timely and efficient testing of staff in order to ensure safety.

Rationing resources fairly

The surging COVID-19 cases can drive companies in the US healthcare industry into an agonizing emergency scenario and will require caregiver to take several crucial decisions. Rationing the available resources fairly to meet the demand of the rising number of cases would be one of the most crucial decisions to be made. The resources include ICU, ventilators, medicines, and staff to care for the patients.  One of the first steps in managing available resources is screening outpatients who are unlikely to need critical care and urging them to self-quarantine at home. Providers in the US healthcare industry must also strive to look at the cases and try to evaluate as quickly and efficiently as possible the likelihood that they can improve a patient’s condition faster.

Set patient treatment guidelines

Providers in the US healthcare industry Hospitals could adopt a lottery or first-come-first-served system for triaging patients. However, this could mean that someone less sick is treated before an infected patient who needs critical care, thereby potentially failing to achieve the goal of saving the most lives. Hospitals could choose to treat worse-off patients first, but if those people are unlikely to survive, doctors might be better off focusing on people who are less infected. However, the chances of survival of these guidelines in an extreme crisis situation remain to be seen. Professionals in the US healthcare industry are of the opinion that as the US currently lacks an exact historical comparison for how the coronavirus pandemic could play out, these guidelines offer general principles for steering hospital decision-making. Having predetermined guidelines prove helpful not just for determining which patients to treat but also on how long to treat them.

Undertake extensive testing

Timely and rapid testing for healthcare workers as well as the general public with symptoms, and those who are asymptomatic is the need of the hour to help the US healthcare industry to prepare better for what lies ahead. Apart from the clinical benefits to COVID-19 testing such as creating an action plan for treating low- and high-risk patients, the primary purpose of testing during a pandemic is advancing public health. Testing allows tracking who has COVID-19 and can help limit the community spread of the virus.

Want more insights on how our healthcare market intelligence solutions can help stakeholders in the US healthcare industry to better organize patient treatment plans, allocate medical resources, and be better equipped to fight the pandemic?

Health care innovation

Preparing for Health care Innovation: How Organizations can Capture Success

With the increased need for accountability, health care quality and patient-centered care, organizations in the sector are increasingly chasing innovation. Health care innovation is crucial to solving some critical challenges in patient care as well as operational efficiency. However, a recent survey by healthcare industry experts states that less than 30% of healthcare providers across the globe are mature in their ability to access, integrate, and analyze healthcare data from diverse sources.

Those still resorting to conventional methods of healthcare are in the threat of being left behind amidst transformations in the healthcare sector. Most of them see health care innovation as highly challenging to implement and often are unsure as to where they should begin. This article describes some key processes that can help organizations demystify the process of health care innovation and ensure a smooth transition.

Transforming health care delivery into a system that is more value-based and patient-centric will require a commitment to change, whether it’s a radical innovation, incremental innovation. Request a free proposal for insights on how your organization can prepare for health care innovation in the long run.

Invention and innovation are not the same

Many organizations often make the mistake of defining innovation as the use of novel technologies, processes or even business models. However, any new technology, at least in the early stages, can only be regarded as an invention. Although inventions are vital, only when these inventions rise to the widespread adoption to transform behavior and functioning of users or organizations can they be termed as innovations. If an invention is not successful in scaling progress at different levels in the organization, it does not become an innovation.

Innovations do not always require radical change

The size of innovation can vary from organization to organization. They can be either radical or even incremental. Health care innovation can be in the form of adopting a new approach to an existing service such as a material improvement on minimally invasive techniques or it can even mean offering a new service that redefines organizations’ existing processes. Continuous incremental healthcare innovation can help organizations learn whether the changes are favorable to their organization or not and adjust their course accordingly.

Radical innovation requires choreography

Several organizations dread radical health care innovation as they believe that this could turn the entire operations of their organization upside down and could cause inconvenience to some degree. This attitude can sometimes have catastrophic outcomes for healthcare companies. Choreographing radical innovation requires healthcare companies to be honest with themselves about their change management prowess. It also necessitates them to take steps to improve it if necessary. They must put into play a mechanism to assess and incorporate all the complementary strategies necessary to execute the

Learn more about our custom portfolio of services for healthcare organizations

Crohn’s disease

Unique challenges plaguing Europe’s digital healthcare efforts

As the concept of digital healthcare goes global, healthcare stakeholders across geographies are evaluating new tools, while innovators are navigating pathways to implement advanced technologies into healthcare. Over the past decade, the European healthcare system has progressed leaps and bounds. However, the sector is bound by some major challenges including aging population, greater prevalence of chronic diseases, shortage of healthcare workers, and financial discrepancies of care. In order to put a strong fight against the increasing healthcare challenges, the European healthcare sector is now embracing digital innovations and new technologies now more than ever before. But what are the major roadblocks to successful implement digital healthcare technologies in Europe?

Addressing barriers to the full use of digital healthcare solutions in Europe requires a comprehensive action plan. Request a free proposal from our experts for more insights on how our solutions can help MedTech companies identify and tackle critical roadblocks with agility.

Digital healthcare challenges in Europe

Meeting regulatory requirements

The regulatory issues with digital health technologies are highly complicated. The EU is planning to roll out Medical Device Regulation in May and this is also said include regulations relating to digital health technologies. This could mean that out of several medical device that are surveyed, only a few may be compliant with the regulations by the time they go into effect. New medical device regulations that would come into effect this year would require strict and stronger clinical evidence for clinical technologies.

Highly fragmented market

The EU is creating increased regulations around MedTech. However, there are several hurdles to implementation on a country to country basis. MedTech startups in Europe build at a regional level before expanding. This is common trend in the US as well. However, the challenge here is that the systems are designed and developed for a local setting in the initial phase but launching the same system in another country could prove to be a tedious task the regulations and requirements across countries may vary. Setting up digital healthcare technology in a new EU country poses not just regulatory barriers but also logistical ones, such as infrastructure.

Finding funding for digital healthcare

Funding is another major challenge that digital healthcare innovators need to navigate in Europe. Seed-stage financing and early rounds should not be a challenge for digital healthcare startups in Europe because public funds can be sourced from countries like Germany and Portugal that make early-stage investments. There are also several venture capitalists across Europe that can also help with funding. Several US-based investors have been known to provide backing to Europe-grown startups. However, since Europe is a highly fragmented market, finding success across different countries in Europe may be challenging, making it difficult for digital health companies to find investors.

Want more insights on our solutions and how we can help businesses plan for digital healthcare challenges in Europe?

consumer engagement

Exploring New Horizons of Consumer Engagement in Healthcare: Key Touchpoints to Work On

As key stakeholders in the healthcare industry are working towards improving patient care and reducing the cost of care, experts at Infiniti Research identify three key touchpoints of consumer engagement in the patient journey to focus on to achieve this.

Consumer engagement in the healthcare industry continues to grow with the advancements in technology. From identifying and accessing new channels of care to monitoring and sharing healthcare data, consumers are now actively engaged with their healthcare and treatment decisions. Healthcare industry experts believe that consumer engagement in healthcare could be instrumental in achieving better patient outcomes and reducing costs. Patients who are well-informed and well involved in their treatment process are more likely to have better health outcomes and also incur lower costs comparatively.

According to experts at Infiniti Research, there are typically three key touchpoints in the consumer engagement with healthcare providers wherein their active interaction peaks: while the consumer searches for care, when they gain access new channels of healthcare such as digital tools and at-home testing, and while sharing personal health information with the providers. As life sciences and healthcare organizations continue to evolve, their strategies must also transform to accommodate the changing healthcare consumer expectations. In this article, we offer strategies for healthcare providers to enhance their key consumer engagement touchpoints.

Consumer engagement in healthcare can hold profound potential benefits for healthcare. Want more insights on strategies to capitalize on them better? Request a free proposal from our industry experts.

Enhancing consumer touchpoints in healthcare

Searching for healthcare and providers

One of the key points of consumer engagement in healthcare involves finding the right healthcare providers to cover their treatment needs. Some of the important factors that affect these decisions include physician’s availability in their health plan’s network, reputation, convenient hours, and the costs. Technology for scheduling and accessing lab tests online is another critical consideration especially for the younger generation of healthcare consumers. This indicates that healthcare consumers are laying increased focus on the quality ratings, convenience, cost, and accessibility of services.

Using new healthcare channels

Healthcare consumers are increasingly becoming open to new channels of treatment through digital tools and apps. Investing in digital tools and at-home diagnostic tests have the potential to enhance health outcomes through faster diagnosis, round-the-clock access to health coaching, and the ability to recognize mood and lifestyle changes that could affect adherence to a treatment plan. Thereby, the quality of patient care can be ensured with reduced hospitalization and treatment costs.

Tracking and sharing personal healthcare data

Relying on technology to track health and monitor fitness has become a prominent trend over the past decade. The data generated through wearable devices that capture health and fitness data can help significantly improve population health, advance clinical research, and enhance the performance of the device. Consumers are also becoming more willing to share this data with their personal doctors to improve their care. Sharing this data can help both providers and consumers be more proactive in their health management. However, today data often resides in multiple medical records across different providers. This makes the complete picture of a patient’s health unavailable to doctors, researchers, and the consumers themselves. Consequently, it becomes difficult for people to get the targeted care they need at the most critical times. Several companies have introduced applications to help consumers manage their data and collate medical records. But this may require interoperability between the various organizations that currently store consumers’ health data.

Learn more about our solutions that can help healthcare providers stay updated with the latest market trends, new healthcare industry challenges, and strategize for creating better care-giving facilities in the long run.  

Electronic health records

Finding the Future of Electronic Health Records in the US

Electronic health recordsThe proliferation of diagnostics and screening tests in the United States has generated massive amounts of patient data. To effectively store and manage these mounting volumes of data, the US health systems have invested over $20 billion in electronic health records (EHR systems) over the past decade. Based on the data from our healthcare market intelligence, over 85% of healthcare providers and physicians in the United States had access to EHR systems by the end of 2017. Although electronic medical records are poised to revolutionize patient care by putting patient information at the doctor’s fingertips, not all physicians are content with its implementation. Physicians often find themselves caught up in data entry with limited time for patient interactions. Moreover, electronic health records are currently far from being the panacea of patient safety and operational efficiency that they were expected to be. However, as electronic health records system matures, we can expect the future of electronic health records to live up to their potential in the long run.

Several challenges must be overcome to make electronic health records more integrated, including endless customization, vendor market share protection, health system market share protection, and technological factors. Are you an EHR vendor facing a similar dilemma? RFP to know how our solutions can help.

Future of electronic health records : Key roadblocks to overcome

Electronic health recordsSiloed systems

Prior to the implementation of electronic health records in the US, healthcare providers and patients were unable to effectively follow patient in time and space. Furthermore, such siloed systems added on to the hospital expenditure and wastage of physician time, restricting the provision for a better quality of care. EHR systems have the potential to mobilize hospital’s resources and enhance the overall patient outcome. But a major challenge of EHR systems is that various vendors had separately developed systems with different data formatting, making it difficult to share patient records between hospitals, physicians and external testing labs. This also makes it challenging to use data collected by patient monitoring devices. The Fast Healthcare Interoperability Resources (FHIR) draft standard is trying to develop a standard for storing and transmitting data across healthcare organizations. And this is now being widely accepted by vendors of electronic health records systems. The recent regulations proposed by the IS government health insurance plan might soon make FHIR mandatory for electronic health records.

Reducing physician’s data entry work

Natural language processing is a great way to reduce the time spent on data entry work for physicians and facilitates them to allot more time to patients. However, this comes with its own set of challenges. Firstly, the clarity of the output will largely depend on the physician’s way with words. This could hamper the reliability of the report. Secondly, with such technology, patient privacy is at stake. Although countries like the US and UK have strong medical data privacy regulations, especially in the case of data transmission, we still come across data breach instances. Such breaches can lead to healthcare fraud especially in the case of medical insurance.

Choosing the right EHR system that fits the needs of your organization can be challenging. Get in touch with an expert from Infiniti Research and learn how we help clients better understand organizational requirements and identify solutions that fulfill organizational needs effectively.

Managing data entry errors

One of the key advantages of electronic health records was believed to be its ability to reduce errors, misplacement, and oversights in healthcare records. Also, in many cases, the illegibility of physicians’ handwriting was found to be the cause of several errors. Although the introduction of electronic medical records has reduced instances of medical errors considerably, the chances of errors cannot be completely ruled out. Digitalization could also pave for new opportunities for medical error. Drug safety authorities have confirmed that human-computer interactions were responsible for over 50% of problems in laboratory testing. This could drastically hamper patient care by causing inconvenience, errors or delays in diagnosis. Although electronic health records systems are designed to alert clinicians in case of mistakes, often these alerts are shrugged off as a ‘computer error’ and this in some cases could prove to be fatal for patients. In order to reduce the risk of alert fatigue causing similar mistakes in the future, it is advisable to switch off the most frequently ignored alerts.

Learn more about Infiniti’s solutions for healthcare companies

Surgical consumables

A Surgical consumable Manufacturing Company Successfully Expanded Their Business Operations Across 5 Countries in the EMEA Region

Surgical Consumables Market Overview

Increasing sophistication in medical procedures and improved success rate, owing to the rising use of advanced consumables and services provided in hospitals are projected to drive the global surgical consumables market. In addition, the presence of advanced healthcare infrastructure is playing a pivotal role in the growth of the surgical consumables market. Moreover, the increase in robot-assisted surgeries are expected to create numerous opportunities for companies in the surgical consumables market. However, the rising concerns regarding hospital-acquired infections (HAIs) are impelling governments to encourage the use of disposable hospital consumables in the US. As such, companies in the surgical consumable market will need to focus on developing reusable or disposable surgical consumables.

Top Markets: North America holds the largest share in the surgical consumables market and is expected to retain its dominance for the next five years. The experts at Infiniti Research predict that Europe, Asia-Pacific, and LAMEA will witness steady growth over the next two years.

Top Segments: Diagnostic supplies, dialysis consumables, radiology consumables, infusion products, intubation & ventilation supplies, hypodermic products, sterilization consumables, nonwoven medical supplies, and wound care consumables.

As the healthcare industry becomes more competitive, surgical consumables manufacturing companies will need to devise products that yield higher reimbursements and greater profit margins. Our market opportunity analysis can help you to identify growth opportunities and maximize profitability. Request a FREE proposal today!

Key Surgical Consumables Market Challenges Faced by the Client

Our client, a surgical consumables manufacturing firm based out of the United States, wanted to expand their business operations across 5 countries in the EMEA region. Before investing a huge sum into their new expansion project, they wanted to thoroughly analyze the current market scenario and growth opportunities for surgical consumables manufacturers across the 5 target countries in the EMEA region. The sought to partner with Infiniti Research to leverage their expertise in offering market opportunity analysis.

Other major challenges faced by the surgical consumables market client included:

Challenge #1: The client was facing difficulties due to lack of up-to-date data about risk factors involved in the manufacturing of surgical consumables

Challenge #2: To support the manufacturing strategy upgradation plan, the client needed robust insights about competitors and their in-house vs outsourcing vs hybrid models

Challenge #3: Lack of insights into profitable market opportunities and industry developments was a major challenge for the client as this data was vital to stay up-to-date with the latest technologies and processes.

Challenge #4: Understanding the exact opportunity in the market was a challenge considering limited data around Reimbursement/payment structure and current offers provided by competitors.

Our Integrated Approach

The experts at Infiniti Research carried out exhaustive secondary research from proprietary and open source information sources to develop insights and hypothesis specific to the target countries.

As a part of the market opportunity analysis engagement, the experts also provided the client with:

  • Recommendations on the emerging market trends and opportunities in the surgical consumables market
  • Key performance indicators (KPIs) to enable understanding of the focus areas. All the obtained information was evaluated on the KPIs, to generate recommendations for the client to re-align its business strategies for competitive advantage.
  • Market forecast and opportunity model to recommend critical success factors for business expansion

Besides, Infiniti’s market opportunity analysis also involved:

  • Detailed analysis of profiles and pipeline of major players in the surgical consumables market
  • Analysis of unmet needs for a profound understanding on potential opportunities
  • Validation of gathered data through an additional set of open-ended discussions with industry experts to ensure accuracy
  • Complete algorithm and setup for Reimbursement and Pricing Approval Process across 5 countries in the EMEA region

Along with the flourishing healthcare sector, the surgical consumables market is growing rapidly, witnessing the increasing demand in treatment and surgical procedures. Want to learn more about the growth opportunities in the surgical consumables industry? Contact us and our experts will get in touch with you with comprehensive insights.

Results Obtained

By leveraging Infiniti’s market opportunity analysis engagement, the surgical consumables market client was able to:

  • Easily adopt new/innovative manufacturing processes
  • Identify and shortlist most relevant stakeholders in each country, responsible for pricing, coverage, and reimbursement decisions
  • Assess and evaluate the most compelling attributes in each country that impact HTA and Reimbursement Decisions
  • Assess competitors’ offerings, new business strategies and market position
  • Understand their customers, their sources of the market access strategy, and Concerns for healthcare providers
  • Identify the total addressable market and make a robust sales strategy
  • Develop actionable strategies for targeted advertising
  • Enhanced product efficiency and quality
  • Realized profits of over 23% by successfully establishing operations across the target regions

Want to learn more about our services for companies in the surgical consumables market? Request more info here!

Medical implants market

A Medical Implants Supplier Gained 11% Market Share in its New Product Category with Market Assessment Study

Medical Implants Market Overview

The global medical implants market is witnessing a surge in the demand owing to rising disposable income, better medical facilities, significant technological advancements, rise in healthcare expenditure, and rising prevalence of chronic diseases. Additionally, rising healthcare demands in developing countries are expected to lead to the growth of the medical implants market around the globe. However, factors such as high costs of implantation, stringent regulatory framework, inadequate reimbursement policies, and lack of skilled health care professionals are inhibiting the growth of the medical implants market. Furthermore, market dynamics are also rapidly changing. As such, companies in the medical implants market will need to reduce costs, advance in technology, streamline operations, and innovate quickly.

Top Markets: The United States holds the largest share of the global medical implants market, followed by Europe. The experts at Infiniti Research predict that the Asia-Pacific region will showcase explosive growth through 2021.

Top segments in the medical implants market: Orthopedic implants, cardiac implants, spinal implants, dental implants, and cosmetic implants

By following sophisticated research methodologies, we track and analyze market trends and competitive activities to help you identify global opportunities and maximize growth. Request a FREE proposal and our experts will help you develop winning strategies.

Key medical implants market challenges faced by the client

An American medical implants manufacturer and supplier was looking to develop an advanced orthopedic implant for the North American market. In order to ensure the commercial success of the new device, the client wanted the product to meet the needs and expectations of end-users such as physicians and support staffs. In addition, the client wanted to track innovations and trends and identify technology areas that provide the best commercial opportunity.

The company in the medical implants market also wanted to:

  • Navigate technological disruption with a better understanding of the technology landscape and a strategic roadmap for investment
  • Identify technologies that are most likely to confer a competitive advantage in the near and long-term in the medical implants market
  • Understand the technology adoption trends in their focus industry and identify the changes that need to be made to compete effectively

Our Integrated Approach

To help the client tackle the industry challenges, the experts at Infiniti Research conducted rigorous desk research of the latest innovations in the North American medical implants market through 750+ sources.

As a part of the market assessment, the experts also conducted:

  • Company analysis and profiling to identify areas that need improvement
  • Market potential assessment to identify and evaluate potential investment areas in the medical implants market
  • Concept testing to check the viability of introducing the new product in the North American medical implants market
  • Pricing research to draw the relationship between the product’s features and pricing to determine the optimal price point

Furthermore, Infiniti’s market assessment involved:

  • Development of a go-to-market opportunity roadmap
  • Setup for new product pricing approval policy in North America
  • Product testing and approval process
  • Identification of physicians needs and requirements

We help healthcare players to address market challenges by analyzing the key factors that drive the undercurrents of change in healthcare. Contact us today to know more about our services for companies in the medical implants market.

Results Obtained

By leveraging Infiniti’s market assessment, the company in the medical implants market was able to:

  • Gain a better understanding of the technology landscape and identify the changes that need to be made in their new medical device to compete effectively
  • Track the latest innovations and trends and identify technology areas that provide the best commercial opportunity in the medical implants industry
  • Develop a sound go-to-market opportunity roadmap for their new product launch
  • Estimate the profit potential for their new medical device for the next five years
  • Gain 11% market share in its new product category, generating $2.8 million in savings

Copy of New infographics 2020

We meet the sales, marketing, product development, and innovation needs of companies across all industries and help them adapt to market and technology changes. Request for more info to gather more insights into our services and their benefits for your business.

Digital healthcare

Digital Healthcare in Canada: What Needs to be Done to Enable Smooth Transition

Although Canadians are keen about implementing digital healthcare, their healthcare system lags behind. To drive improved healthcare outcomes, the Canadian government must focus on adopting healthcare innovations, customer-driven models, and a new regulatory framework that facilitates change and embraces digital healthcare.

What is digital healthcare services?

Digital healthcare services is a simple concept. It encompasses using technology to improve health and wellness of patients. Today, the term digital healthcare includes electronic health (health-related information, resources, and services provided electronically) as well as developing areas such as advanced computing science ( big data that can provide valuable insights into population health) and artificial intelligence (AI), wherein computer systems perform tasks that would normally require human capacities, such as decision-making. With new healthcare solutions constantly changing the way we live, it is fair to say that the future of healthcare is digital.

Adoption and use of digital healthcare technologies have the potential to make healthcare delivery more accessible, convenient, and cost-effective. Request a free proposal to know how your organization can enable a smooth transition to digital healthcare services.

Canada ranks among the lowest when compared to other OECD countries that have universal healthcare systems. Healthcare consumers becoming increasingly empowered by the volume and ease of access to healthcare information, even so, the current model for healthcare delivery remains unchanged fundamentally. A number of challenges will have to be addressed at the national, provincial, and territorial level in Canada to create an environment wherein the current model can incorporate digital healthcare tools. While the journey towards a fully patient and family-centric approach to healthcare will be long, there are some measures that governments could initiate in order to accelerate the process and implement digital healthcare more effectively.

Digital healthcareAdjust fees paid to physicians

The Canadian government must ensure that fair and adequate compensation is given to physicians for virtual consultations. Some provinces such as British Columbia and Alberta have implemented pilots of revised fee structures, albeit a pan-Canadian strategy is yet to be implemented for revised compensation. In such situations, if the physician billing structure has been modified in a particular province to allow virtual consultations, interprovincial licensing and regulations might restrict physicians from being able to employ these changes across provincial borders.

Partner with us to know how you can identify opportunities to make your healthcare system more patient-centric and improve accessibility. Get in touch with us to know more about how our solutions can help your healthcare organization.

Common strategy for adoption of healthcare innovation

A common nation-wide strategy must be adopted by the Canadian government to better implement innovations such as digital healthcare. By establishing incubators and accelerators, the government is currently encouraging and supporting an entrepreneurial culture in the business sector. By incorporating this as a part of a nationally designed vision for the future of healthcare, new solutions for healthcare can be encouraged. Healthcare strategy should largely revolve around the patient, their family, and the caregiver rather than on systems and institutions. A comprehensive analysis of the customer experience of healthcare companies will provide valuable insights into the opportunities of realizing efficiency through the application of digital healthcare solutions.

Policy framework for digital healthcare solutions

The federal and provincial governments in Canada should collaboratively design a policy framework for the effective adoption of secure digital healthcare solutions. Innovative healthcare technologies will ensure secure data oversight through cloud solutions and blockchain, consequently paving the way for shared policies and standards. Through this, providers will be able to take full advantage of the significant data generated by single-payer health care system. Moreover, this will also ensure that all Canadians can use their individual health data in partnership with their health professionals to identify personalized healthcare solutions.

Learn more about Infiniti’s solutions for the healthcare industry

Infiti Logo

Hello there!

Contact us to know more about our cost-effective custom market research offerings to support efficient market penetration, new product launch, and devise strategies to monitor and outperform your competitors.

Cookie Policy

The Site uses cookies to record users' preferences in relation to the functionality of accessibility. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice